Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing high-dose therapy using pharmacokinetic principles

P E Zorsky1, J B Perkins

  • 1Division of Bone Marrow Transplantation, University of South Florida College of Medicine, Tampa.

Seminars in Oncology
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience.

Bone marrow transplantation·2015
Same author

Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission.

Bone marrow transplantation·2013
Same author

Development of sampling and analytical methods for concerted determination of commonly used chloroacetanilide, chlorotriazine, and 2,4-D herbicides in hand-wash, dermal-patch, and air samples.

Applied occupational and environmental hygiene·2001
Same author

Oxidative stress in humans during work at moderate altitude.

The Journal of nutrition·1999
Same author

Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer.

Seminars in oncology·1998
Same author

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.

Bone marrow transplantation·1998
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Maximizing cancer treatment effectiveness through dose intensity is supported by bone marrow transplant outcomes. Optimizing individual patient drug doses requires understanding drug concentration-toxicity relationships for better therapeutic results.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Therapeutics

Background:

  • The concept of "dose intensity" in oncology suggests higher effective drug therapy intensity may improve cure rates.
  • Bone marrow transplantation (BMT) for various cancers supports this hypothesis, overcoming initial bone marrow suppression.
  • Individual patient tolerance to high-dose therapy varies due to interpatient variability in drug concentration, leading to unpredictable organ toxicities.

Purpose of the Study:

  • To examine the concept of dose intensity in oncology.
  • To define dose intensity using plasma drug concentrations.
  • To review methods for controlling individual patient therapy and optimizing outcomes.

Main Methods:

  • Review of oncologic literature focusing on "dose intensity" and bone marrow transplantation outcomes.

Related Experiment Videos

  • Analysis of the relationship between drug dose, plasma drug concentration, and toxicity.
  • Exploration of methods to predict and control drug concentration for individual patients.

    • Main Results:

    • Dose intensity is a key concept in oncology, particularly supported by BMT results.
    • Interpatient variability in drug concentration significantly impacts toxicity and outcomes.
    • Defining relationships between drug concentration, area under the curve, and toxicity is crucial for high-dose therapy.

    Conclusions:

    • Optimizing cancer therapy requires precise control of drug doses based on individual patient pharmacokinetics.
    • Understanding drug concentration-toxicity relationships is essential for maximizing therapeutic benefits while minimizing life-threatening toxicities.
    • Predictive models are needed to achieve more precise control of high-dose cancer therapy in individual patients.